Drug-related nail disease

Clinics in Dermatology

Volumn 31, Issue 5, 2013, Pages 618-626

  Piraccini, Bianca Maria ^a   Alessandrini, Aurora ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBAMAZEPINE; CEFALORIDINE; CETUXIMAB; CISPLATIN; CLOXACILLIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DAUNORUBICIN; DIURETIC AGENT; DOCETAXEL; DOXORUBICIN; EFAVIRENZ; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; FLUCLOXACILLIN; FLUOROURACIL; INDINAVIR; LAPATINIB; LITHIUM CARBONATE; PANITUMUMAB; PSORALEN; PSYCHOTROPIC AGENT; QUINOLONE DERIVATIVE; RETINOID; TAXANE DERIVATIVE; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG; VALPROIC ACID;

ACNE; APPARENT LEUKONYCHIA; BEAU LINE; CAUSAL ATTRIBUTION; DIGITAL GANGRENE; DRUG EFFICACY; DRUG EXCRETION; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG RESPONSE; DRUG USE; GANGRENE; HUMAN; KERATINIZATION; MUCOSA INFLAMMATION; NAIL BLEEDING; NAIL DISEASE; NAIL PIGMENTATION; NOTE; ONYCHOLYSIS; ONYCHOMADESIS; PARONYCHIA; PATHOGENESIS; PHOTOONYCHOLYSIS; PRIORITY JOURNAL; PRURITUS; PYOGENIC GRANULOMA; RADIATION DERMATITIS; RADIOTHERAPY; RAYNAUD PHENOMENON; TREATMENT INDICATION; TRUE LEUKONYCHIA; XEROSIS;

ANTINEOPLASTIC AGENTS; DRUG ERUPTIONS; FINGERS; GRANULOMA, PYOGENIC; HEMORRHAGE; HUMANS; HYPERPIGMENTATION; HYPOPIGMENTATION; NAIL DISEASES; ONYCHOLYSIS; PARONYCHIA; PROTEIN KINASE INHIBITORS; TOES;

EID: 84884687560     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2013.06.013     Document Type: Note

References (56)

1. Minisini A.M., Tosti A., Sobrero A.F., et al. Taxane-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol 2003, 14:333-337.
2. Park J., Li K. Images in clinical medicine. Multiple Beau's lines. N Engl J Med 2010, 362:e63.
3. Eastwood J.B., Curtis J.R., Smith E.K., et al. Shedding of nails apparently induced by the administration of large amounts of cephaloridine and cloxacillin in two anephric patients. Br J Dermatol 1969, 81:750-752.
4. Poretti A., Lips U., Belvedere M., et al. Onychomadesis: a rare side-effect of valproic acid medication?. Pediatr Dermatol 2009, 26:749-750.
5. Grossman M., Scher R.K. Leukonychia. Review and classification. Int J Dermatol 1990, 29:535-541.
6. Ceyhan A.M., Yildirim M., Bircan H.A., et al. Transverse leukonychia (Mees' lines) associated with docetaxel. J Dermatol 2010, 37:188-189.
7. Parakh A., Kocchar A.M. Chemotherapy induced transverse leukonychia (Mees, lines). Indian Pediatr 2007, 44:865.
8. Antonarakis E.S. Images in clinical medicine. Acquired leukonychia totalis. N Engl J Med 2006, 355:e2.
9. Chen G.Y., Chen W., Huang W.T. Single transverse apparent leukonychia caused by 5-fluorouracil plus leucovorin. Dermatology 2003, 207:86-87.
10. Lehoczky O., Pulay T. Transverse leukonychia secondary to paclitaxel-carboplatin chemotherapy in a patient with ovarian cancer. J Obstet Gynaecol 2002, 22:694.
11. Saray Y., Seckin D., Güleç A.T., et al. Nail disorders in hemodialysis patients and renal transplant recipients: a case-control study. J Am Acad Dermatol 2004, 50:197-202.
12. Eros N., Marschalkó M., Bajcsay A., et al. Transient leukonychia after total skin electron beam irradiation. J Eur Acad Dermatol Venereol 2011, 25:115-117.
13. Daniel C.R., Piraccini B.M., Tosti A. The nail and hair in forensic science. J Am Acad Dermatol 2004, 50:258-261.
14. Huang T.C., Chao T.Y. Mees lines and Beau lines after chemotherapy. CMAJ 2010, 182:E149.
15. Onder M., Oztaş M.O., Oztaş P. Isotretinoin-induced nail fragility and onycholysis. J Dermatolog Treat 2001, 12:115-116.
16. Badri T., Hawilo A.M., Benmously R., et al. Acitretin-induced pyogenic granuloma. Acta Dermatovenerol Alp Panonica Adriat 2011, 20:217-218.
17. Teknetzis A., Ioannides D., Vakali G., et al. Pyogenic granulomas following topical application of tretinoin. J Eur Acad Dermatol Venereol 2004, 18:337-339.
18. Piraccini B.M., Iorizzo M., Starace M., et al. Drug-induced nail diseases. Dermatol Clin 2006, 24:387-391.
19. Teknetzis A., Ioannides D., Vakali G., et al. Pyogenic granulomas following topical application of tretinoin. J Eur Acad Dermatol Venereol 2004, 18:337-339.
20. Baran R. Pyogenic granuloma-like lesions associated with topical retinoid therapy. J Am Acad Dermatol 2002, 47:970.
21. Pierson J.C., Owens N.M. Pyogenic granuloma-like lesions associated with topical retinoid therapy. J Am Acad Dermatol 2001, 45:967-968.
22. Dawkins M.A., Clark A.R., Feldman S.R. Pyogenic granuloma-like lesion associated with topical tazarotene therapy. J Am Acad Dermatol 2000, 43:154-155.
23. Lau C.P., Hui P., Chan T.C. Docetaxel-induced nail toxicity: a case of severe onycholysis and topic review. Chin Med J (Engl) 2011, 124:2559-2560.
24. Truchuelo M., Vano-Galvan S., Pérez B., et al. Unilateral taxane-induced onychopathy in a patient with a brain metastasis. Dermatol Online J 2009, 15:7.
25. Sanches Junior J.A., Brandt H.R., Moure E.R., et al. Adverse mucocutaneous reactions to chemotherapeutic agents: part I. An Bras Dermatol 2010, 85:425-437.
26. Peuvrel L., Quéreux G., Brocard A., et al. Onychopathy induced by temsirolimus, a mammalian target of rapamycin inhibitor. Dermatology 2012, 224:204-208.
27. Wasner G., Hilpert F., Baron R., Pfisterer J. Clinical picture: nail changes secondary to docetaxel. Lancet 2001, 357:910.
28. Baran R., Juhlin L. Photoonycholysis. Photodermatol Photoimmunol Photomed 2002, 18:202-207.
29. Bentabet Dorbani I., Badri T., Benmously R., et al. Griseofulvin-induced photo-onycholysis. Presse Med 2012, 41:879-881.
30. Muehrcke R.C. The finger-nails in chronic hypoalbuminemia; a new physical sign. Br Med J 1956, 1:1327-1328.
31. Piraccini B.M., Bellavista S., Misciali C., et al. Periungual and subungual pyogenic granuloma. Br J Dermatol 2010, 163:941-953.
32. Luther J., Glesby M.J. Dermatologic adverse effects of antiretroviral therapy: recognition and management. Am J Clin Dermatol 2007, 8:221-233.
33. Choi J.N. Chemotherapy-induced iatrogenic injury of skin: new drugs and new concepts. Clin Dermatol 2011, 29:587-601.
34. Lacouture M.E., Anadkat M.J., Bensadoun R.J., et al. Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Support Care Cancer 2011, 19:1079-1095.
35. Deslandres M., Sibaud V., Chevreau C., et al. Cutaneous side effects associated with epidermal growth factor receptor and tyrosine kinase inhibitors. Ann Dermatol Venereol 2008, 1:16-24.
36. Bonny M., Buyse V., Brochez L. Dermatological side effects of current and upcoming targeted therapies in oncology. Acta Clin Belg 2011, 66:97-103.
37. Aydogan K., Karadogan S.K., Tunali S. Acitretin-induced subungual hemorrhage. Int J Dermatol 2007, 46:494-495.
38. von Gunten C.F., Roth E.L., Von Roenn J.H. Raynaud phenomenon in three patients with acquired immune deficiency syndrome-related Kaposi sarcoma treated with bleomycin. Cancer 1993, 72:2004-2006.
39. Reiser M., Bruns C., Hartmann P., et al. Raynaud's phenomenon and acral necrosis after chemotherapy for AIDS-related Kaposi's sarcoma. Eur J Clin Microbiol Infect Dis 1998, 17:58-60.
40. Kynaston H.G., Roberts D.H., Davies W.T. Peripheral gangrene associated with beta-blockade. Br J Surg 1987, 74:760.
41. Aghoutane E.M., Fezzazi R., Elhaouati R., et al. Fingers necrosis after an accidental intra-arterial injection of flucloxacilline: case report. Chir Main 2011, 30:120-122.
42. Jefferson J., Rich P. Melanonychia. Dermatol Res Pract 2012, 2012:952186.
43. Paurobally D., El Hayderi L., Richert B., et al. Melanotan-associated transverse melanonychia. J Eur Acad Dermatol Venereol 2013, 27:128-129.
44. André J., Lateur N. Pigmented nail disorders. Dermatol Clin 2006, 24:329-339.
45. Dixit V.B., Chaudhary S.D., Jain V.K. Clofazimine induced nail changes. Indian J Lepr 1989, 61:476-478.
46. Ban M., Kitajima Y. Nail discoloration occurring after 8 weeks of minocycline therapy. J Dermatol 2007, 34:699-701.
47. Tavares J., Leung W.W. Discoloration of nail beds and skin from minocycline. CMAJ 2011, 183:224.
48. Kalabalikis D., Patsatsi A., Trakatelli M.G., et al. Hyperpigmented forearms and nail: a quiz. Acta Derm Venereol 2010, 90:657-659.
49. Teive H.A., Munhoz R.P. Rotigotine-induced nail dyschromia in a patient with Parkinson disease. Neurology 2011, 76:1605.
50. Gregoriou S., Kazakos C., Rigopoulos D. Yellow chromonychia after ascorbic acid application. Clin Exp Dermatol 2011, 36:671-672.
51. Ghosh S., Mukhopadhyay S. Chemical leucoderma: a clinico-aetiological study of 864 cases in the perspective of a developing country. Br J Dermatol 2009, 160:40-47.
52. Piraccini B.M., Alessandrini A., Bruni F., et al. Acute periungueal dermatitis induced by application of urea-containing cream under occlusion. J Dermatol Case Rep 2012, 6:18-20.
53. Raulin C., Frosch P.J. Contact allergy to imidazole antimycotics. Contact Dermatitis 1988, 18:76-80.
54. Dooms-Goossens A., Matura M., Drieghe J., et al. Contact allergy to imidazoles used as antimycotic agents. Contact Dermatitis 1995, 33:73-77.
55. Pérez-Varela L., Goday-Buján J., Piñeyro-Molina F., et al. Allergic contact dermatitis due to amorolfine in nail lacquer. Actas Dermosifiliogr 2010, 101:281-283.
56. Rigopoulos D., Katsambas A., Antoniou C., et al. Discoloration of the nail plate due to the misuse of amorolfine 5% nail lacquer. Acta Derm Venereol 1996, 76:83-84.